Market Cap 63.64M
Revenue (ttm) 0.00
Net Income (ttm) -80.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 288,800
Avg Vol 124,268
Day's Range N/A - N/A
Shares Out 31.35M
Stochastic %K 4%
Beta 0.85
Analysts Strong Sell
Price Target $19.62

Latest News on ACRV

What To Buy After You Sell The Russell 2000

Apr 3, 2024, 3:07 AM EDT - 1 year ago

What To Buy After You Sell The Russell 2000

AVUV IJR IWM IWN MLYS NXT SKWD


Acrivon: Precision-Testing Your Trial Patients Before Enrolment

Mar 26, 2023, 9:53 AM EDT - 2 years ago

Acrivon: Precision-Testing Your Trial Patients Before Enrolment


Acrivon Therapeutics sets IPO price range

Nov 3, 2022, 7:52 AM EDT - 2 years ago

Acrivon Therapeutics sets IPO price range


Acrivon Therapeutics Begins U.S. IPO Rollout

Oct 19, 2022, 11:50 AM EDT - 2 years ago

Acrivon Therapeutics Begins U.S. IPO Rollout